A. Ucan Et Al. , "Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case–control study," Virology Journal , vol.18, no.1, 2021
Ucan, A. Et Al. 2021. Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case–control study. Virology Journal , vol.18, no.1 .
Ucan, A., Cerci, P., EFE, S., Akgun, H., Ozmen, A., Yagmuroglu, A., ... BİLGİN, M.(2021). Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case–control study. Virology Journal , vol.18, no.1.
Ucan, Anıl Et Al. "Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case–control study," Virology Journal , vol.18, no.1, 2021
Ucan, Anıl Et Al. "Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case–control study." Virology Journal , vol.18, no.1, 2021
Ucan, A. Et Al. (2021) . "Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case–control study." Virology Journal , vol.18, no.1.
@article{article, author={Anıl Ucan Et Al. }, title={Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case–control study}, journal={Virology Journal}, year=2021}